PuSH - Publikationsserver des Helmholtz Zentrums München

Reilly, M.P.* ; Li, M.* ; He, J.* ; Ferguson, J.F.* ; Stylianou, I.M.* ; Mehta, NN.* ; Burnett, M.S.* ; Devaney, J.M.* ; Knouff, C.W.* ; Thompson, J.R.* ; Horne, B.D.* ; Stewart, A.F.* ; Assimes, T.L.* ; Wild, P.S.* ; Allayee, H.* ; Nitschke, P.L.* ; Patel, RS* ; Myocardial Infarction Genetics Consortium (*) ; Wellcome Trust Case Control Consortium. (*) ; Martinelli, N.* ; Girelli, D.* ; Quyyumi, A.A.* ; Anderson, J.L.* ; Erdmann, J.* ; Hall, A.S.* ; Schunkert, H.* ; Quertermous, T.* ; Blankenberg, S.* ; Hazen, S.L.* ; Roberts, R.* ; Kathiresan, S.* ; Peters, A. ; Wichmann, H.-E. ; Samani, N.J.* ; Epstein, S.E.* ; Rader, D.J.

Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: Two genome-wide association studies.

Lancet 377, 383-392 (2011)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
BACKGROUND: We tested whether genetic factors distinctly contribute to either development of coronary atherosclerosis or, specifically, to myocardial infarction in existing coronary atherosclerosis. METHODS: We did two genome-wide association studies (GWAS) with coronary angiographic phenotyping in participants of European ancestry. To identify loci that predispose to angiographic coronary artery disease (CAD), we compared individuals who had this disorder (n=12,393) with those who did not (controls, n=7383). To identify loci that predispose to myocardial infarction, we compared patients who had angiographic CAD and myocardial infarction (n=5783) with those who had angiographic CAD but no myocardial infarction (n=3644).FINDINGS: In the comparison of patients with angiographic CAD versus controls, we identified a novel locus, ADAMTS7 (p=4·98×10(-13)). In the comparison of patients with angiographic CAD who had myocardial infarction versus those with angiographic CAD but no myocardial infarction, we identified a novel association at the ABO locus (p=7·62×10(-9)). The ABO association was attributable to the glycotransferase-deficient enzyme that encodes the ABO blood group O phenotype previously proposed to protect against myocardial infarction. INTERPRETATION: Our findings indicate that specific genetic predispositions promote the development of coronary atherosclerosis whereas others lead to myocardial infarction in the presence of coronary atherosclerosis. The relation to specific CAD phenotypes might modify how novel loci are applied in personalised risk assessment and used in the development of novel therapies for CAD. FUNDING: The PennCath and MedStar studies were supported by the Cardiovascular Institute of the University of Pennsylvania, by the MedStar Health Research Institute at Washington Hospital Center and by a research grant from GlaxoSmithKline. The funding and support for the other cohorts contributing to the paper are described in the webappendix.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter SINGLE-NUCLEOTIDE POLYMORPHISMS; VON-WILLEBRAND-FACTOR; ARTERY-DISEASE; SUSCEPTIBILITY LOCUS; CHROMOSOME 9P21; COMPLEX TRAITS; METAANALYSIS; LINKAGE; IMPUTATION; EFFICIENT
ISSN (print) / ISBN 0140-6736
e-ISSN 0099-5355
Zeitschrift Lancet, The
Quellenangaben Band: 377, Heft: 9763, Seiten: 383-392 Artikelnummer: , Supplement: ,
Verlag Elsevier
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Epidemiology II (EPI2)